The New York Jets hosted their 20th Annual Kickoff Luncheon at Cipriani Wall Street on Monday. Jets coaches, players and legends came together at the green carpet event to help raise roughly $750,000 to benefit both the New York Jets Foundation and the Lupus Research Alliance, and to give fans a glimpse of the upcoming year.
Ken Farber, President and CEO of the Lupus Research Alliance, spoke about the relationship with the Jets and how the luncheon has assisted in providing funds for research, technology and opportunities to find cures for lupus.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.